Dyspepsia and constipation in patients with schizophrenia spectrum disorders

References

• Iacovides A, Siamouli M. Comorbid mental and somatic disorders: an epidemiological perspective. Curr Opin Psychiatry 2008;21:417–21.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Munk-Olsen T, Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One 2011;6:e24597.
   PubMed Web of Science ®Google Scholar
• Nielsen J, Correll CU, Manu P, Kane JM. Termination of clozapine treatment due to medical reasons: When is it warranted and how can it be avoided? J Clin Psychiatry 2013;74:603–13.
   PubMed Web of Science ®Google Scholar
• Cohen D, Bogers JP, van Dijk D, Bakker B, Schulte PF. Beyond white blood cell monitoring: Screening in the initial phase of clozapine therapy. J Clin Psychiatry 2012;73:1307–12.
   PubMed Web of Science ®Google Scholar
• De Hert M, Dockx L, Bernagie C, Peuskens B, Sweers K, Leucht S, et al. Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: A retrospective descriptive study. BMC Gastroenterol 2011;11:17.
   PubMed Web of Science ®Google Scholar
• Ozbilen M, Adams CE. Systematic overview of Cochrane reviews for anticholinergic effects of antipsychotic drugs. J Clin Psychopharmacol 2009;29:141–6.
   PubMed Web of Science ®Google Scholar
• Nielsen J, Meyer JM. Risk factors for ileus in patients with schizophrenia. Schizophr Bull 2012;38:592–8.
   PubMed Web of Science ®Google Scholar
• Bharucha AE, Pemberton JH, Locke GR. American gastroenterological association technical review on constipation. Gastroenterology 2013;144:218–38.
   PubMed Web of Science ®Google Scholar
• Ford AC, Moayyedi P. Dyspepsia. BMJ 2013;347:f5059.
   PubMed Web of Science ®Google Scholar
• Taylor D, Olofinjana O, Rahimi T. Use of antacid medication in patients receiving clozapine: A comparison with other second-generation antipsychotics. J Clin Psychopharmacol 2010;30:460–1.
   PubMed Web of Science ®Google Scholar
• Miwa H, Watari J, Fukui H, Oshima T, Tomita T, Sakurai J, et al. Current understanding of pathogenesis of functional dyspepsia. J Gastroenterol Hepatol 2011;26:53–60.
   PubMed Web of Science ®Google Scholar
• Eskelinen S, Sailas E, Joutsenniemi K, Holi M, Suvisaari J. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia. Nord J Psychiatry 2015;69:339–45.
   PubMed Web of Science ®Google Scholar
• Kestila L, Koskinen S, Martelin T, Rahkonen O, Pensola T, Pirkola S, et al. Influence of parental education, childhood adversities, and current living conditions on daily smoking in early adulthood. Eur J Public Health 2006;16:617–26.
   PubMed Web of Science ®Google Scholar
• Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007;31:1208–17.
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L, Tibblin G, Werko L. A primary preventive study of Gothenburg, Sweden. Prev Med 1972;1:153–60.
   PubMedGoogle Scholar
• WONCA ICC. International Classification of Primary Care ICPC-2 R. 2nd ed. New York: Oxford University Press; 2005.
   Google Scholar
• Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: A meta-analysis. Gut 2015;64:1049–57.
   PubMed Web of Science ®Google Scholar
• Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME. Epidemiology of constipation in Europe and Oceania: A systematic review. BMC Gastroenterol 2008;8:5.
   PubMed Web of Science ®Google Scholar
• Liao CH, Chang CS, Chang SN, Muo CH, Lane HY, Sung FC, et al. The association of peptic ulcer and schizophrenia: A population-based study. J Psychosom Res 2014;77:541–6.
   PubMed Web of Science ®Google Scholar
• Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: An update. Schizophr Bull 2014;40:181–91.
   PubMed Web of Science ®Google Scholar
• Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil 2007;19:905–11.
   PubMed Web of Science ®Google Scholar
• Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Willett WC. Use of acetaminophen and nonsteroidal anti-inflammatory drugs: A prospective study and the risk of symptomatic diverticular disease in men. Arch Fam Med 1998;7:255–60.
   PubMedGoogle Scholar
• Stubbs B, Mitchell AJ, De Hert M, Correll CU, Soundy A, Stroobants M, et al. The prevalence and moderators of clinical pain in people with schizophrenia: A systematic review and large scale meta-analysis. Schizophr Res 2014;160:1–8.
   PubMed Web of Science ®Google Scholar
• Bouchoucha M, Uzzan B, Cohen R. Metformin and digestive disorders. Diabetes Metab 2011;37:90–6.
   PubMed Web of Science ®Google Scholar
• Boland BS, Edelman SV, Wolosin JD. Gastrointestinal complications of diabetes. Endocrinol Metab Clin North Am 2013;42:809–32.
   PubMed Web of Science ®Google Scholar
• Sagy R, Weizman A, Katz N. Pharmacological and behavioral management of some often-overlooked clozapine-induced side effects. Int Clin Psychopharmacol 2014;29:313–7.
   PubMed Web of Science ®Google Scholar
• Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14:119–36.
   PubMed Web of Science ®Google Scholar
• Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003;60:82–91.
   PubMed Web of Science ®Google Scholar
• Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014;109:S2–S26.
   PubMed Web of Science ®Google Scholar
• Hynes C, Keating D, McWilliams S, Madigan K, Kinsella A, Maidment I, et al. Glasgow antipsychotic side-effects scale for clozapine: Development and validation of a clozapine-specific side-effects scale. Schizophr Res 2015;168:505–13.
   PubMed Web of Science ®Google Scholar
• De Hert M, De Beugher A, Sweers K, Wampers M, Correll CU, Cohen D. Knowledge of psychiatric nurses about the potentially lethal side-effects of clozapine. Arch Psychiatr Nurs 2016;30:79–83.
   PubMed Web of Science ®Google Scholar
• Palmer SE, McLean RM, Ellis PM, Harrison-Woolrych M. Life-threatening clozapine-induced gastrointestinal hypomotility: An analysis of 102 cases. J Clin Psychiatry 2008;69:759–68.
   PubMed Web of Science ®Google Scholar
• van Veggel M, Olofinjana O, Davies G, Taylor D. Clozapine and gastro-esophageal reflux disease (GORD): An investigation of temporal association. Acta Psychiatr Scand 2013;127:69–77.
   PubMed Web of Science ®Google Scholar
• Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: Systematic review and meta-analysis. Am J Gastroenterol 2011;106:1582–91.
   PubMed Web of Science ®Google Scholar
• Suvisaari J, Keinanen J, Eskelinen S, Mantere O. Diabetes and schizophrenia. Curr Diab Rep 2016;16:16.
   PubMed Web of Science ®Google Scholar
• Zheng W, Li XB, Tang YL, Xiang YQ, Wang CY, de Leon J. Metformin for weight gain and metabolic abnormalities associated with antipsychotic treatment: Meta-analysis of randomized placebo-controlled trials. J Clin Psychopharmacol 2015;35:499–509.
   PubMed Web of Science ®Google Scholar